Hillsdale Investment Management’s Novo Nordisk NVO Stock Holding History

Hillsdale Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-280	Closed	-$10K	–	643
2020 Q4	$10K	Sell	280 -60	-18%	-$2.07K	﹤0.01%	496
2020 Q3	$12K	Buy	340 +160	+89%	+$5.33K	﹤0.01%	484
2020 Q2	$6K	Buy	+180	New	+$5.74K	﹤0.01%	495
2018 Q4	–	Sell	-800	Closed	-$19K	–	631
2018 Q3	$19K	Hold	800	–	–	﹤0.01%	323
2018 Q2	$18K	Hold	800	–	–	﹤0.01%	339
2018 Q1	$20K	Hold	800	–	–	﹤0.01%	317
2017 Q4	$21K	Hold	800	–	–	﹤0.01%	326
2017 Q3	$19K	Hold	800	–	–	﹤0.01%	335
2017 Q2	$17K	Hold	800	–	–	﹤0.01%	330
2017 Q1	$14K	Sell	800 -320	-29%	-$5.57K	﹤0.01%	329
2016 Q4	$20K	Hold	1,120	–	–	﹤0.01%	326
2016 Q3	$24K	Hold	1,120	–	–	0.01%	351
2016 Q2	$31K	Hold	1,120	–	–	0.01%	358
2016 Q1	$31K	Sell	1,120 -80	-7%	-$2.14K	0.01%	345
2015 Q4	$35K	Hold	1,200	–	–	0.01%	347
2015 Q3	$33K	Buy	1,200 +800	+200%	+$22.7K	0.01%	422
2015 Q2	$11K	Hold	400	–	–	﹤0.01%	476
2015 Q1	$11K	Sell	400 -4,000	-91%	-$92.1K	﹤0.01%	478
2014 Q4	$93K	Hold	4,400	–	–	0.02%	395
2014 Q3	$105K	Hold	4,400	–	–	0.03%	380
2014 Q2	$102K	Hold	4,400	–	–	0.02%	382
2014 Q1	$100K	Sell	4,400 -14,000	-76%	-$298K	0.03%	377
2013 Q4	$340K	Sell	18,400 -1,000	-5%	-$17.4K	0.1%	154
2013 Q3	$328K	Hold	19,400	–	–	0.1%	169
2013 Q2	$301K	Buy	+19,400	New	+$323K	0.1%	175

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hillsdale Investment Management's NVO Position: Q1 2021 in Review

Hillsdale Investment Management sold out of Novo Nordisk (NVO) in Q1 2021, closing a stake of 280 shares — an estimated $10K sold.

Hillsdale Investment Management first reported a position in NVO in Q2 2013 and held it in 25 quarters. The position peaked at $340K in Q4 2013. 708 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

Hillsdale Investment Management reported no remaining Novo Nordisk position as of Q1 2021 after selling out during the quarter.
Hillsdale Investment Management sold 280 Novo Nordisk shares in Q1 2021, an estimated $10K.
Hillsdale Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 25 quarters.
Hillsdale Investment Management's Novo Nordisk position peaked at $340K in Q4 2013.
708 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on Hillsdale Investment Management's 13F filing for Q1 2021, filed 22 Apr 2021.